“…The number of medications based on active pharmaceutical ingredients (API) in the form of salts and complexes has increased in recent decades, both in the total number and in the number of cations used [ 1 , 2 , 3 ]. This growth is related to ability of cations to tune physical chemical properties of an API, such as solubility or tabletability [ 4 , 5 , 6 , 7 , 8 ], and increased selectivity of their supramolecular binding with biological macromolecules and/or bioactivity [ 9 , 10 ], as well as to the existence of metallopharmaceuticals [ 11 , 12 , 13 , 14 ], metallodrugs, and bioMOFs with controlled release of API [ 15 , 16 , 17 , 18 , 19 , 20 ]. The Orange Book of Approved Drug Products with Therapeutic Equivalence Evaluations [ 21 ] contains information about salts of sodium, potassium, calcium, magnesium, iron, platinum, silver, and zinc.…”